American Well Corporation ( (AMWL) ) has released its Q3 earnings. Here is a breakdown of the information American Well Corporation presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
American Well Corporation, commonly known as Amwell, is a prominent provider of a comprehensive SaaS-based technology-enabled healthcare platform, specializing in telehealth services that integrate AI-driven automation with certified care providers to enhance clinical and financial outcomes.
In its third-quarter earnings report for 2025, Amwell reported financial results that exceeded its previous guidance, highlighting the company’s strategic focus on achieving break-even cash flow from operations by the end of 2026. The company emphasizes its role in addressing the challenges of fragmented healthcare solutions by offering a unified platform that enhances operational efficiency and customer value.
Key financial metrics for the third quarter included a total revenue of $56.3 million, surpassing prior guidance, with subscription revenue reaching $30.9 million and Amwell Medical Group visit revenue at $21.2 million. Despite a net loss of $31.9 million, the company reported a gross margin of 52.4%. Amwell’s adjusted EBITDA stood at a loss of $12.7 million, reflecting an increase from the previous quarter’s loss. The company also revised its annual revenue guidance to a range of $245 million to $248 million, while narrowing its adjusted EBITDA guidance.
Looking ahead, Amwell remains committed to its goal of achieving positive cash flow from operations in 2026. The company continues to focus on leveraging its technology platform to provide scalable, reliable, and flexible healthcare solutions that meet the evolving needs of healthcare organizations, positioning itself for future growth in the telehealth market.